Assembly Biosciences Inc
Assembly Biosciences Inc (ASMB) Options Open Interest
ASMB options open interest is 1,386 contracts. The 2-week average daily volume is 72 contracts across the chain.
Read more
Monitoring ASMB open interest helps you see where real money is positioned on Assembly Biosciences Inc's options and which strikes are attracting the most commitment from traders. Assembly Biosciences Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ASMB options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ASMB options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Assembly Biosciences Inc to settle.
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc.
to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ASMB open interest is concentrated. Our scanner maps Assembly Biosciences Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Assembly Biosciences Inc's options open interest as the signal it is, not as an afterthought.
| 35.00 | — | 1.60 | 1.60 | 159% | +0.2899 | 73 |
| 45.00 | 0.15 | 1.15 | 0.65 | 163% | +0.1379 | 20 |
| 30.00 | 0.30 | 1.20 | 0.75 | 83% | +0.2478 | 8 |
| 40.00 | — | 4.90 | 4.90 | 320% | +0.4603 | 1 |
| 15.00 | 8.10 | 12.50 | 10.30 | 138% | +0.9395 | 0 |
| 35.00 | 7.70 | 12.00 | 9.85 | 12% | -1.0000 | 54 |
| 25.00 | 0.80 | 2.00 | 1.40 | 52% | -0.4666 | 43 |
| 30.00 | 3.00 | 7.50 | 5.25 | 60% | -0.8453 | 21 |
| 45.00 | 17.50 | 22.00 | 19.75 | 19% | -1.0000 | 2 |
| 40.00 | 12.50 | 17.00 | 14.75 | 15% | -1.0000 | 1 |
As of September 18, 2026
Follow the money
Track ASMB open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→